|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
DE2010115A1
(de)
|
1970-03-04 |
1971-09-16 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Verfahren zur Herstellung von Mikrogranulaten
|
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
US4474572A
(en)
|
1981-09-29 |
1984-10-02 |
Syntex (U.S.A.) Inc. |
Implanting device and implant magazine
|
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
US4758435A
(en)
|
1986-08-11 |
1988-07-19 |
American Cyanamid Company |
Estradiol implant composition and method for preparation
|
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
US4900552A
(en)
|
1988-03-30 |
1990-02-13 |
Watson Laboratories, Inc. |
Mucoadhesive buccal dosage forms
|
|
WO1991008231A1
(en)
|
1989-11-29 |
1991-06-13 |
Brigham And Women's Hospital |
[Ala IL-8]77 AS A LEUKOCYTE ADHESION INHIBITOR
|
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
|
US5122377A
(en)
*
|
1990-11-19 |
1992-06-16 |
A.H. Robins, Company, Incorporated |
Oral delivery system for veterinary drugs
|
|
EP0551626A1
(en)
|
1991-12-19 |
1993-07-21 |
LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. |
Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
EP0688429B1
(en)
|
1993-03-09 |
1998-02-11 |
Epic Therapeutics, Inc.. |
Macromolecular microparticles and methods of production
|
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
US5421818A
(en)
|
1993-10-18 |
1995-06-06 |
Inner Ear Medical Delivery Systems, Inc. |
Multi-functional inner ear treatment and diagnostic system
|
|
TW438601B
(en)
|
1994-05-18 |
2001-06-07 |
Janssen Pharmaceutica Nv |
New mucoadhesive emulsion compositions and a process for the preparation thereof
|
|
WO1996000081A1
(en)
|
1994-06-24 |
1996-01-04 |
Immunex Corporation |
Controlled release polypeptide compositions and methods of treating inflammatory bowel disease
|
|
GB9505032D0
(en)
|
1995-03-13 |
1995-05-03 |
Westminster Lab Ltd |
Improvements in or relating to organic compositions
|
|
IL112834A
(en)
|
1995-03-01 |
2000-12-06 |
Yeda Res & Dev |
Pharmaceutical compositions for controlled release of soluble receptors
|
|
FR2742357B1
(fr)
|
1995-12-19 |
1998-01-09 |
Rhone Poulenc Rorer Sa |
Nanoparticules stabilisees et filtrables dans des conditions steriles
|
|
US6379911B2
(en)
|
1996-02-23 |
2002-04-30 |
Albert Einstein College Of Medicine Of Yeshiva University |
Enzyme detection/assay method and substrates
|
|
EP0938499A1
(en)
|
1996-07-19 |
1999-09-01 |
Amgen Inc. |
Analogs of cationic proteins
|
|
US5945126A
(en)
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
|
US6045528A
(en)
|
1997-06-13 |
2000-04-04 |
Intraear, Inc. |
Inner ear fluid transfer and diagnostic system
|
|
US5939421A
(en)
|
1997-07-01 |
1999-08-17 |
Signal Pharmaceuticals, Inc. |
Quinazoline analogs and related compounds and methods for treating inflammatory conditions
|
|
WO1999015210A2
(en)
|
1997-09-26 |
1999-04-01 |
Noven Pharmaceuticals, Inc. |
Bioadhesive compositions and methods for topical administration of active agents
|
|
US5985848A
(en)
|
1997-10-14 |
1999-11-16 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibitors of nucleoside metabolism
|
|
GB9812426D0
(en)
|
1998-06-10 |
1998-08-05 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
|
US6319513B1
(en)
|
1998-08-24 |
2001-11-20 |
The Procter & Gamble Company |
Oral liquid mucoadhesive compounds
|
|
US20020009478A1
(en)
|
1998-08-24 |
2002-01-24 |
Douglas Joseph Dobrozsi |
Oral liquid mucoadhesive compositions
|
|
US6270802B1
(en)
|
1998-10-28 |
2001-08-07 |
Oakwood Laboratories L.L.C. |
Method and apparatus for formulating microspheres and microcapsules
|
|
CA2696826C
(en)
|
1999-04-08 |
2013-01-08 |
Industrial Research Limited |
Process for preparing inhibitors of nucleoside metabolism
|
|
DK1180159T3
(da)
|
1999-05-28 |
2008-11-17 |
Targeted Genetics Corp |
Fremgangsmåder og sammensætninger til at sænke niveauet af Tumor-Nekrose-Faktor (TNF) i TNF-associerede lidelser
|
|
NZ516348A
(en)
|
1999-06-23 |
2003-06-30 |
Aventis Pharma Gmbh |
Substituted benzimidazole
|
|
US6458387B1
(en)
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
|
US7151191B2
(en)
|
2000-01-13 |
2006-12-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
GB0003154D0
(en)
|
2000-02-12 |
2000-04-05 |
Astrazeneca Uk Ltd |
Novel compounds
|
|
EP1268477B1
(en)
|
2000-03-15 |
2010-04-21 |
Sanofi-Aventis Deutschland GmbH |
Substituted beta-carbolines with ikb-kinase inhibiting activity
|
|
DK1292680T3
(da)
|
2000-06-22 |
2010-03-08 |
Genentech Inc |
Agonist-anti-TrkC monoklonale antistoffer
|
|
US20020013331A1
(en)
|
2000-06-26 |
2002-01-31 |
Williams Robert O. |
Methods and compositions for treating pain of the mucous membrane
|
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
|
WO2002018371A1
(en)
|
2000-08-29 |
2002-03-07 |
Industrial Research Limited |
Nucleoside metabolism inhibitors
|
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
|
WO2002026219A2
(en)
*
|
2000-09-25 |
2002-04-04 |
Bayer Healthcare Llc |
Otic microbial combinations for treatment of animals with ruptured tympanic membrane
|
|
JP2004532797A
(ja)
|
2000-10-12 |
2004-10-28 |
スミスクライン・ビーチャム・コーポレイション |
NF−κB阻害剤
|
|
JP2004523476A
(ja)
|
2000-10-12 |
2004-08-05 |
スミスクライン・ビーチャム・コーポレイション |
NF−κB阻害剤
|
|
NZ525474A
(en)
|
2000-10-26 |
2005-10-28 |
Tularik Inc |
Antiinflammation agents
|
|
JP2002193938A
(ja)
|
2000-12-01 |
2002-07-10 |
Bayer Ag |
4−アリールピリジン誘導体
|
|
US7122544B2
(en)
|
2000-12-06 |
2006-10-17 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
|
|
AU2002246956B2
(en)
|
2001-01-04 |
2006-11-02 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof
|
|
SE0100158D0
(sv)
|
2001-01-19 |
2001-01-19 |
Synphora Ab |
Novel method and composition for local treatment of Meniere´s disease and tinnitus
|
|
CA2436770A1
(en)
|
2001-02-01 |
2002-08-08 |
James R. Burke |
Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk)
|
|
FR2823441B1
(fr)
*
|
2001-04-12 |
2004-09-10 |
Thea Lab |
Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
|
|
US20030045515A1
(en)
|
2001-05-24 |
2003-03-06 |
Lise Binderup |
Combination medicament for treatment of neoplastic diseases
|
|
WO2002094265A1
(en)
|
2001-05-24 |
2002-11-28 |
Leo Pharma A/S |
A method of modulating nf-$g(k)b activity
|
|
SE0102617D0
(sv)
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
|
US6956052B2
(en)
|
2001-09-19 |
2005-10-18 |
Pharmacia Corporation |
Substituted pyrazolyl compounds for the treatment of inflammation
|
|
ES2286275T3
(es)
|
2001-09-19 |
2007-12-01 |
Pharmacia Corporation |
Compuestos de pirazolo sustituidos para el tratamiento de la inflamacion.
|
|
ATE414697T1
(de)
|
2001-10-04 |
2008-12-15 |
Smithkline Beecham Corp |
Nf-kb-inhibitoren
|
|
JP2005528331A
(ja)
|
2001-11-21 |
2005-09-22 |
イェシバ・ユニバーシティ |
Sir2産物および活性
|
|
CA2468544A1
(en)
|
2001-12-10 |
2003-06-19 |
Amgen Inc. |
Vanilloid receptor ligands
|
|
CA2473796A1
(en)
|
2002-01-17 |
2003-07-31 |
Neurogen Corporation |
Substituted quinazolin-4-ylamine analogues
|
|
JP2003277383A
(ja)
|
2002-03-14 |
2003-10-02 |
Bayer Ag |
光学活性ピリジン誘導体およびそれを含む医薬
|
|
US7098334B2
(en)
|
2002-03-25 |
2006-08-29 |
Industrial Research Limited |
4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
|
|
WO2003099284A1
(en)
|
2002-05-22 |
2003-12-04 |
Amgen Inc. |
Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
|
|
US7022680B2
(en)
|
2002-05-30 |
2006-04-04 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases
|
|
FR2841243B1
(fr)
*
|
2002-06-19 |
2004-08-20 |
Servier Lab |
Nouveaux derives de 3-(4-oxo-4h-chromen-2yl)-(1h)-quinolein- 4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
AR041191A1
(es)
|
2002-08-08 |
2005-05-04 |
Amgen Inc |
Ligandos del receptor vanilloide y su uso en tratamientos
|
|
US7220431B2
(en)
*
|
2002-11-27 |
2007-05-22 |
Regents Of The University Of Minnesota |
Methods and compositions for applying pharmacologic agents to the ear
|
|
US7582635B2
(en)
|
2002-12-24 |
2009-09-01 |
Purdue Pharma, L.P. |
Therapeutic agents useful for treating pain
|
|
US20040185047A1
(en)
|
2003-03-21 |
2004-09-23 |
Jill Giles-Komar |
Anti- TNF antibodies, compositions, methods and uses
|
|
ES2338119T3
(es)
|
2003-04-21 |
2010-05-04 |
Eli Lilly And Company |
Benzopiranos sustituidos como agonistas selectivos del receptor-beta de estrogeno.
|
|
US20040247575A1
(en)
|
2003-06-03 |
2004-12-09 |
Caplice Noel M. |
Smooth muscle progenitor cells
|
|
US7329664B2
(en)
|
2003-07-16 |
2008-02-12 |
Neurogen Corporation |
Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues
|
|
PT1648878E
(pt)
|
2003-07-24 |
2009-07-23 |
Euro Celtique Sa |
Compostos de piperidina e composições farmacêuticas que os contêm
|
|
US7390907B2
(en)
|
2003-09-30 |
2008-06-24 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
CA2551097A1
(en)
|
2003-12-23 |
2005-07-14 |
Rinat Neuroscience Corp. |
Agonist anti-trkc antibodies and methods using same
|
|
TW200530235A
(en)
|
2003-12-24 |
2005-09-16 |
Renovis Inc |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
|
US7312330B2
(en)
|
2003-12-24 |
2007-12-25 |
Renovis, Inc. |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
|
US20060063802A1
(en)
|
2004-03-29 |
2006-03-23 |
Matthieu Guitton |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
|
US8268866B2
(en)
|
2004-03-29 |
2012-09-18 |
Matthieu Guitton |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
|
WO2005113544A1
(en)
|
2004-05-12 |
2005-12-01 |
Aventis Pharmaceuticals Inc. |
Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor
|
|
WO2005115527A2
(en)
|
2004-05-24 |
2005-12-08 |
Auris Medical, Llc. |
Combined otic aspirator and medication dispenser
|
|
US8498681B2
(en)
|
2004-10-05 |
2013-07-30 |
Tomophase Corporation |
Cross-sectional mapping of spectral absorbance features
|
|
US20060105967A1
(en)
|
2004-11-18 |
2006-05-18 |
Advanced Gene Technology, Corp. |
Flavone derivatives as TNFalpha inhibitors or antagonists
|
|
UA88663C2
(en)
*
|
2004-12-09 |
2009-11-10 |
Баер Энимал Хелс Гмбх |
Stabilisation of glucocorticoid esters with acids
|
|
DE102005055385A1
(de)
*
|
2004-12-09 |
2006-06-14 |
Bayer Healthcare Ag |
Arzneimittel zur hygienischen Applikation im Ohr
|
|
EP1827498A2
(de)
|
2004-12-09 |
2007-09-05 |
Bayer HealthCare AG |
Stabilisierung von glucocorticoidestern mit säuren
|
|
AR053114A1
(es)
|
2005-01-12 |
2007-04-25 |
Aventis Pharma Inc |
Sal monopotasica del acido 2-{[2-(-2-metilamino-pirimidin-4-il)-1h-indol-5-carbonil]-amino}-3-(fenilpiridin-2-il-amino)-propionico,inhibidora de ikk-2 quinasa
|
|
EP1850840A2
(en)
|
2005-01-13 |
2007-11-07 |
Sirtris Pharmaceuticals, Inc. |
Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
|
|
WO2006076646A2
(en)
|
2005-01-14 |
2006-07-20 |
Neurogen Corporation |
Heteroaryl substituted quinolin-4-ylamine analogues
|
|
JP2008528613A
(ja)
|
2005-01-25 |
2008-07-31 |
ニューロジェン・コーポレーション |
置換ピリダジニル−及びピリミジニル−キノリン−4−イルアミン類縁体
|
|
US20060221197A1
(en)
|
2005-03-30 |
2006-10-05 |
Jung Edward K |
Image transformation estimator of an imaging device
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
JP2008531726A
(ja)
|
2005-03-04 |
2008-08-14 |
ニューロシステック コーポレイション |
改良されたガシクリジン製剤
|
|
WO2006095263A1
(en)
|
2005-03-10 |
2006-09-14 |
Pfizer Japan Inc. |
Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
|
|
EP1863757A4
(en)
|
2005-03-14 |
2012-02-22 |
Evotec Ag |
AMIDE DERIVATIVES AS IONIC CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
|
|
EP1861359B1
(en)
|
2005-03-17 |
2012-11-14 |
Pfizer Inc. |
N-(n-sulfonylaminomethyl)cyclopropanecarboxamide derivatives useful for the treatment of pain
|
|
EP1893583B1
(en)
|
2005-05-31 |
2012-04-04 |
Pfizer Inc. |
Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
|
|
US7785834B2
(en)
|
2005-11-10 |
2010-08-31 |
Ercole Biotech, Inc. |
Soluble TNF receptors and their use in treatment of disease
|
|
US20070219272A1
(en)
|
2006-02-06 |
2007-09-20 |
Johan Stjernschantz |
Novel method and compositions for treatment of tinnitus
|
|
WO2007111457A2
(en)
|
2006-03-24 |
2007-10-04 |
Lg Electronics Inc. |
A method and structure of configuring preamble to support transmission of data symbol in a wireless communication system
|
|
US7744746B2
(en)
|
2006-03-31 |
2010-06-29 |
Exxonmobil Research And Engineering Company |
FCC catalyst stripper configuration
|
|
CA2661576A1
(en)
*
|
2006-09-26 |
2008-04-03 |
Taro Pharmaceuticals North America, Inc. |
Stabilizing compositions for antibiotics and methods of use
|
|
US8377898B2
(en)
|
2006-10-12 |
2013-02-19 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
|
MX2009006794A
(es)
|
2006-12-20 |
2009-07-02 |
Rinat Neuroscience Corp |
Agonistas del receptor tirosina quinasa b para el tratamiento de trastornos autoinmunes.
|
|
CN101990433B
(zh)
|
2008-02-07 |
2014-11-05 |
马萨诸塞眼科耳科诊所 |
提高Atoh1表达的化合物
|
|
MX2010011545A
(es)
*
|
2008-04-21 |
2011-04-11 |
Otonomy Inc |
Formulaciones para tratar enfermedades y afecciones del oido.
|
|
WO2012027821A1
(en)
|
2010-09-03 |
2012-03-08 |
The Royal Institution For The Advancement Of Learning / Mcgill University |
A trkc receptor agonist antibody to treat neurodegenerative and motor neuron diseases
|
|
WO2012047706A2
(en)
|
2010-10-06 |
2012-04-12 |
Massachusetts Eye & Ear Infirmary |
Methods for promotiing reinnervation of auditory hair cells
|
|
US9157064B2
(en)
|
2011-01-24 |
2015-10-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for generating inner ear cells in vitro
|
|
WO2013054330A1
(en)
*
|
2011-10-10 |
2013-04-18 |
Otic Pharma Ltd. |
Foam formulations
|
|
DE202012100195U1
(de)
|
2012-01-19 |
2012-03-01 |
Nordmark Arzneimittel Gmbh & Co. Kg |
Neue Verwendung einer pharmazeutischen Zusammensetzung, enthaltend Ancrod
|
|
EP2817009A1
(en)
|
2012-02-23 |
2014-12-31 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Calcineurin inhibitors for use in the treatment of lesional vestibular disorders
|
|
WO2013173803A2
(en)
*
|
2012-05-17 |
2013-11-21 |
Michael Spector |
Formulations of amoxicillin and clavulanate potassium and methods for using same
|
|
WO2013178763A1
(en)
|
2012-05-30 |
2013-12-05 |
Sensorion |
Methods for treating vestibulotoxicity
|
|
EP3378476A1
(en)
|
2012-06-08 |
2018-09-26 |
Sensorion |
H4 receptor inhibitors for treating tinnitus
|
|
CA2883896C
(en)
|
2012-09-07 |
2023-03-07 |
Massachusetts Eye & Ear Infirmary |
Treating hearing loss
|
|
EP2853533A1
(de)
|
2013-09-29 |
2015-04-01 |
Audiocure Pharma GmbH |
6-Fluor-9-methyl-ß-carbolin
|
|
US10603295B2
(en)
|
2014-04-28 |
2020-03-31 |
Massachusetts Eye And Ear Infirmary |
Sensorineural hair cell differentiation
|
|
JP2017522360A
(ja)
|
2014-07-29 |
2017-08-10 |
オトノミー,インク. |
耳垢症の処置のための耳科用製剤
|
|
FR3024361B1
(fr)
|
2014-07-30 |
2017-11-24 |
Affichem |
Utilisation de derives de sterols pour traitement de la perte auditive neurosensorielle et composition correspondante
|
|
EP2982382A1
(en)
|
2014-08-04 |
2016-02-10 |
Sensorion |
Compounds for preventing ototoxicity
|
|
WO2016022776A2
(en)
|
2014-08-06 |
2016-02-11 |
Massachusetts Eye And Ear Infirmary |
Increasing atoh1 life to drive sensorineural hair cell differentiantion
|
|
DE202015100655U1
(de)
*
|
2015-02-03 |
2016-02-04 |
Bio.Lo.Ga. S.R.L. |
Pharmazeutische Zusammensetzung zur topischen Anwendung im Gehörgang
|
|
HK1245657A1
(zh)
|
2015-02-11 |
2018-08-31 |
Support-Venture Gmbh |
预防或治疗听力损失的方法
|
|
JO3491B1
(ar)
|
2015-07-07 |
2020-07-05 |
Audion Therapeutics |
مركبات مثبطة لإشارات مسار notch
|